Track JD Health International Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

JD Health International Inc. 6618.HK · Stock Open JD Health International Inc. in new tab

39.80 HKD
P/E
17.93
EPS
2.17
P/B
1.72
ROE
10.40
Beta
1.19
Target Price
68.71 HKD
Loading chart...
Key Metrics
Earnings dateMarch 29, 2027
P/E17.93
EPS2.17
Book Value22.68
Price to Book1.72
Debt/Equity1.42
% Insiders68.202%
Growth
Revenue Growth0.16%
Earnings Growth0.32%
Estimates
Forward P/E13.20
Forward EPS2.95
Target Mean Price68.71

DCF valuation

Model fair value for JD Health International Inc. (6618.HK)
Result
Sign in to run the valuation for 6618.HK.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 68.71 HKD (low 50.07, high 96.26)
Low 50.07
Mean 68.71
High 96.26
Price 39.80
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

JD Health International Inc. Logo JD Health International Inc. Analysis (6618.HK)

China Healthcare Official Website Stock

Is JD Health International Inc. a good investment? JD Health International Inc. (6618.HK) is currently trading at 39.80 HKD. Market analysts have a consensus price target of 68.71 HKD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 17.93. This valuation is generally in line with the broader market.

Earnings Schedule: JD Health International Inc. is expected to release its next earnings report on March 29, 2027. The market consensus estimate for Forward EPS is 2.95.

Investor FAQ

Does JD Health International Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is JD Health International Inc.?

JD Health International Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be March 29, 2027. The company currently has a trailing EPS of 2.17.

Company Profile

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Exchange Ticker
HKSE 6618.HK
JPX (Japan) 6618.T
PNK (United States) JDHIF
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion